These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19464600)

  • 1. Educational and screening campaigns to reduce deaths from melanoma.
    Geller AC
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):515-27, ix. PubMed ID: 19464600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who attends skin cancer clinics within a randomized melanoma screening program?
    Youl PH; Janda M; Elwood M; Lowe JB; Ring IT; Aitken JF
    Cancer Detect Prev; 2006; 30(1):44-51. PubMed ID: 16457967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Sreening Program.
    Geller AC; Sober AJ; Zhang Z; Brooks DR; Miller DR; Halpern A; Gilchrest BA
    Cancer; 2002 Oct; 95(7):1554-61. PubMed ID: 12237925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous melanoma: public health approach to early detection.
    Weinstock MA
    Dermatol Ther; 2006; 19(1):26-31. PubMed ID: 16405567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of screening in melanoma.
    Stratigos AJ; Katsambas AD
    Clin Dermatol; 2009; 27(1):10-25. PubMed ID: 19095150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005.
    Goldberg MS; Doucette JT; Lim HW; Spencer J; Carucci JA; Rigel DS
    J Am Acad Dermatol; 2007 Jul; 57(1):60-6. PubMed ID: 17490783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing mortality in individuals at high risk for advanced melanoma through education and screening.
    Geller AC; Swetter SM; Oliveria S; Dusza S; Halpern AC
    J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S87-94. PubMed ID: 22018072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What motivates men age > or =50 years to participate in a screening program for melanoma?
    Janda M; Youl PH; Lowe JB; Baade PD; Elwood M; Ring IT; Aitken JF
    Cancer; 2006 Aug; 107(4):815-23. PubMed ID: 16832794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for cutaneous melanoma.
    Lange JR; Balch CM
    Surg Oncol Clin N Am; 2005 Oct; 14(4):799-811. PubMed ID: 16226692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The control of melanoma in New Zealand.
    Sneyd M; Cox B
    N Z Med J; 2006 Sep; 119(1242):U2169. PubMed ID: 16998570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management costs of suspicious skin lesions from a population-based melanoma screening programme.
    Gordon L; Youl PH; Elwood M; Janda M; Ring IT; Lowe JB; Aitken JF
    J Med Screen; 2007; 14(2):98-102. PubMed ID: 17626710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and early detection of melanoma: a surgeon's perspective.
    Reintgen D; Ross M; Bland K; Seigler HF; Balch C
    Semin Surg Oncol; 1993; 9(3):174-87. PubMed ID: 8516600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin cancer screening program in the population of Bydgoszcz].
    Mierzwa T; Zegarski W; Placek W; Zegarska B
    Wiad Lek; 2004; 57 Suppl 1():211-4. PubMed ID: 15884241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996.
    Schneider JS; Moore DH; Mendelsohn ML
    J Am Acad Dermatol; 2008 May; 58(5):741-9. PubMed ID: 18068264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma in the elderly--a neglected public health challenge.
    Kelly JW
    Med J Aust; 1998 Oct; 169(8):403-4. PubMed ID: 9830382
    [No Abstract]   [Full Text] [Related]  

  • 16. Melanoma. Screening and education.
    Ernstoff MS
    Clin Plast Surg; 2000 Jul; 27(3):317-22, vii. PubMed ID: 10941555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of participants in a free oral, head and neck cancer screening program.
    Gourin CG; Kaboli KC; Blume EJ; Nance MA; Koch WM
    Laryngoscope; 2009 Apr; 119(4):679-82. PubMed ID: 19213043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The different psychological profiles of subjects attending melanoma screening campaigns and those delaying diagnosis: an aid for designing preventive campaigns?
    Forghieri M; Longo C; Galeazzi GM; Rigatelli M; Seidenari S; Pellacani G
    Eur J Dermatol; 2010; 20(6):802-7. PubMed ID: 20956101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening, early detection, education, and trends for melanoma: current status (2007-2013) and future directions: Part I. Epidemiology, high-risk groups, clinical strategies, and diagnostic technology.
    Mayer JE; Swetter SM; Fu T; Geller AC
    J Am Acad Dermatol; 2014 Oct; 71(4):599.e1-599.e12; quiz 610, 599.e12. PubMed ID: 25219716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia.
    Geller AC; Elwood M; Swetter SM; Brooks DR; Aitken J; Youl PH; Demierre MF; Baade PD
    Cancer; 2009 Mar; 115(6):1318-27. PubMed ID: 19189368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.